15 March 2017 in News

Stayble gets approval from Swedish MPA to initiate a phase Ib study

Stayble is now very happy to inform that the Swedish MPA has approved our clinical trial phase Ib application. The study will start during April at Stockholm Spine Center. Read more about the clinical trial at https://clinicaltrials.gov/ct2/show/NCT03055845.